7R6X
SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 4.2.2 |
Synchrotron site | ALS |
Beamline | 4.2.2 |
Temperature [K] | 100 |
Detector technology | CMOS |
Collection date | 2020-10-04 |
Detector | RDI CMOS_8M |
Wavelength(s) | 1.00003 |
Spacegroup name | I 41 2 2 |
Unit cell lengths | 245.870, 245.870, 237.310 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 40.000 - 2.950 |
R-factor | 0.2338 |
Rwork | 0.232 |
R-free | 0.26240 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | PDB entries 7JX3 and 7K3Q |
RMSD bond length | 0.003 |
RMSD bond angle | 0.936 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0267) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 49.000 | 49.000 | 2.990 |
High resolution limit [Å] | 2.930 | 14.650 | 2.930 |
Rmerge | 0.295 | 0.048 | 7.868 |
Rmeas | 0.300 | 0.049 | 8.016 |
Rpim | 0.056 | 0.010 | 1.531 |
Total number of observations | 2242103 | 17129 | 123728 |
Number of reflections | 77621 | 692 | 4551 |
<I/σ(I)> | 13.3 | 65.3 | 0.5 |
Completeness [%] | 100.0 | 97.2 | 100 |
Redundancy | 28.9 | 24.8 | 27.2 |
CC(1/2) | 0.998 | 0.998 | 0.381 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293.15 | Crystal 1: 0.09 M phosphate/citrate, pH 5.5, 27% v/v PEG Smear Low, 4% v/v polypropylene glycol 400, 0.02 M imidazole, pH 7, Crystal 2: 0.09 M phosphate/citrate, pH 5.5, 27% v/v PEG Smear Low, 0.01 M potassium/sodium phosphate, pH 7, 1% v/v PPGBA 230, 1.5% v/v PPGBA 400 |